Reference values for forced vital capacity in idiopathic pulmonary fibrosis

被引：0
|
作者：
Pereira, Carlos A. C. [1 ]
机构：
[1] Univ Fed Sao Paulo, Interstitial Lung Dis Program, Sao Paulo, Brazil
来源：
RESPIRATORY MEDICINE | 2017年 / 125卷
关键词：
D O I：
10.1016/j.rmed.2016.11.022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [21] Patients With Idiopathic Pulmonary Fibrosis And Forced Vital Capacity <50% Predicted: Is There A Role For Antifibrotic Therapy?
    Galli, J.
    Pandya, A.
    Dorey-Stein, Z.
    Vega-Olivo, M.
    Criner, G. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [22] Relationship Between MRNA-microRNA Interactions and Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis
    Noth, I.
    Roy, J.
    Schmid, R.
    Vinisko, R.
    Strobel, B.
    Neely, M. L.
    Hesslinger, C.
    Belperio, J. A.
    Flaherty, K. R.
    Salisbury, M. L.
    Oldham, J.
    Palmer, S. M.
    Todd, J. L.
    Leonard, T. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [23] Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis
    Aono, Yuya
    Nakamura, Yutaro
    Kono, Masato
    Nakamura, Hidenori
    Yokomura, Koshi
    Imokawa, Shiro
    Toyoshima, Mikio
    Yasui, Hideki
    Hozumi, Hironao
    Karayama, Masato
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Enomoto, Noriyuki
    Fujisawa, Tomoyuki
    Inui, Naoki
    Suda, Takafumi
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2020, 14
  • [24] Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis Test Properties and Minimal Clinically Important Difference
    du Bois, Roland M.
    Weycker, Derek
    Albera, Carlo
    Bradford, Williamson Z.
    Costabel, Ulrich
    Kartashov, Alex
    King, Talmadge E., Jr.
    Lancaster, Lisa
    Noble, Paul W.
    Sahn, Steven A.
    Thomeer, Michiel
    Valeyre, Dominique
    Wells, Athol U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (12) : 1382 - 1389
  • [25] Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis
    Reichmann, William M.
    Yu, Yanni F.
    Macaulay, Dendy
    Wu, Eric Q.
    Nathan, Steven D.
    BMC PULMONARY MEDICINE, 2015, 15
  • [26] Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis
    William M. Reichmann
    Yanni F. Yu
    Dendy Macaulay
    Eric Q. Wu
    Steven D. Nathan
    BMC Pulmonary Medicine, 15
  • [27] Decline in forced vital capacity (FVC) in subjects with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) compared with healthy references
    Valenzuela, Claudia
    Bonella, Francesco
    Moor, Catharina C.
    Weimann, Gerrit
    Miede, Corinna
    Stowasser, Susanne
    Maher, Toby M.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [28] Decline in forced vital capacity as a surrogate for mortality in patients with pulmonary fibrosis
    Maher, Toby M.
    Stowasser, Susanne
    Voss, Florian
    Bendstrup, Elisabeth
    Kreuter, Michael
    Martinez, Fernando J.
    Sime, Patricia J.
    Stock, Christian
    RESPIROLOGY, 2023, 28 (12) : 1147 - 1153
  • [29] ASSOCIATION OF CHANGE IN FORCED VITAL CAPACITY WITH HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH NEWLY DIAGNOSED IDIOPATHIC PULMONARY FIBROSIS
    Reichmann, W. M.
    Yu, Y.
    Macaulay, D.
    Nathan, S. D.
    VALUE IN HEALTH, 2015, 18 (03) : A259 - A259
  • [30] Predictors of Mortality in Idiopathic Pulmonary Fibrosis: Forced Vital Capacity Decline and Other Surrogate Endpoints - A Literature Review
    Baldwin, M.
    Langham, S.
    Patel, N.
    Pooley, N.
    Ortega, P. Rivera
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
12345